Mount Yale Investment Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$216K Sell
2,029
-1,645
-45% -$199K ﹤0.01% 1121
2026
Q1
$601K Buy
3,674
+1,925
+110% +$296K 0.01% 664
2025
Q4
$304K Buy
+1,749
New +$319K 0.01% 594
2025
Q3
– Sell
-1,685
Closed -$170K – 1117
2025
Q2
$170K Sell
1,685
-1,712
-50% -$131K 0.01% 566
2025
Q1
$259K Sell
3,397
-37
-1% -$2.83K 0.02% 470
2024
Q4
$237K Sell
3,434
-118
-3% -$8.5K 0.02% 500
2024
Q3
$259K Buy
+3,552
New +$262K 0.02% 477

Other funds holding INSM

Mount Yale Investment Advisors's INSM Position: Q2 2026 in Review

Mount Yale Investment Advisors reduced its Insmed (INSM) stake by 45% in Q2 2026, selling an estimated $199K and leaving 2,029 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

Mount Yale Investment Advisors first reported a position in INSM in Q3 2024 and has held it in 7 quarters since. The position peaked at $601K in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Mount Yale Investment Advisors held 2,029 shares of Insmed worth $216K as of Q2 2026.
  • Mount Yale Investment Advisors sold 1,645 Insmed shares in Q2 2026, an estimated $199K.
  • Insmed made up ﹤0.01% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #1121 holding.
  • Mount Yale Investment Advisors first reported a position in Insmed in Q3 2024 and has held it in 7 quarters since.
  • Mount Yale Investment Advisors's Insmed position peaked at $601K in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.